Search results for: Real World Evidence (RWE)
Filter search results
Personalised Medicine: Economic Incentives for Evidence Generation
28 October 2013
…current pricing, evidence and intellectual property approaches. Essential is “building and maintaining a balance” across three sets of factors: Realistic evidence thresholds and payers’ needs for confidence in the clinical…
Making Outcome-based Payment a Reality in the NHS: Moving to the Next Phase
3 October 2019
…addressing uncertainties that were identified (including the quality and completeness of real-world data on key patient outcomes), and by establishing the steps needed to prepare for implementing a pilot outcome-based…
Around the World in HTAs: United States – Making HTA Great Again
11 June 2024
In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Chris Sampson and Dan Ollendorf take us to the United…
The Current Drug Development Paradigm: Responding to US and European Demands for Evidence of Comparative Effectiveness and Relative Effectiveness
1 April 2014
The project reported in this Occasional Paper was intended to determine how changing demands for evidence are affecting drug development in five global pharmaceutical companies: Amgen, Eli Lilly, GSK, Novartis…
Is collaboration between and across regulatory and HTA agencies the answer to access challenges?
12 November 2024
…and challenges. Benefits could include the alignment of methods and evidence requirements on critical topics such as real-world evidence (RWE), the use of artificial intelligence, and considerations of environmental impact…
How Will Demands for Effectiveness Evidence Change Drug Development?
23 April 2014
…in the evidence required for both regulatory approval and reimbursement. This includes in particular evidence about how well new treatments work compared with existing alternatives in the ‘real world’, i.e….
Understanding the Full Value of Long-Acting Therapies: less is more?
7 May 2025
…research community should prioritise generating real-world evidence on LA therapies’ impacts and advance methodologies that quantify societal and environmental benefits. Innovators should incorporate robust evidence generation of broader value elements…
OHE Annual Lecture 2025 | Ten years to turn it around: The economic reality of NHS reform
30 September 2025, 6:00pm
…around the world and to raise awareness of research and evidence that can contribute to addressing these challenges. Throughout our long history we’ve had the privilege of hosting some of…
Venereal Diseases
1 December 1963
…goddess of love. The major venereal diseases are syphilis and gonorrhoea. There are a number of other venereal diseases, including chancroid, lymphogranuloma venereum and granuloma inguinale, but these have been…